Bharat Immunological & Biological Corporation Ltd (524663) — Announcement | 17 September 2026
The filing announces the Government of India's approval to wind up Bharat Immunologicals & Biologicals Corporation Ltd under the Department of Biotechnology's administrative control, marking a formal closure of the company as mandated by Regulation 30 of SEBI's LODR. This regulatory action concludes the company's operational existence without any financial performance or forward-looking statements provided.
About Bharat Immunological & Biological Corporation Ltd (524663)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when 524663 files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track 524663 — Free💡 Ask AI about this filing
📊 More 524663 filings
No other filings yet.
🔥 Also filed on 17 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd